Press release
Gastric Cancer Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | BeiGene, Hutchison MediPharma, Astellas Pharma, Hubro Therapeutics
DelveInsight's "Gastric Cancer Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Gastric Cancer, historical and forecasted epidemiology as well as the Gastric Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Gastric Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gastric Cancer Market Forecast [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Gastric Cancer Market Report:
* The Gastric Cancer market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
* In May 2023, CARsgen Therapeutics, a Chinese biotech firm, initiated a Phase II clinical study of CT041 in the United States. This trial is enrolling participants with advanced gastric cancer or gastroesophageal junction cancer who test positive for Claudin18.2 (CLDN18.2). CT041 is a candidate autologous chimeric antigen receptor (CAR) T-cell therapy designed to target the CLDN18.2 protein.
* The American Cancer Society's projections for gastric cancer in the United States in 2022 indicate approximately 26,380 new cases, comprising 15,900 in men and 10,480 in women. Additionally, it estimates around 11,090 deaths attributed to this form of cancer, with 6,690 among men and 4,400 among women.
* Among the 7MM, Japan (135,592 cases in 2021) has the highest and UK (6,682 cases in 2021) has the lowest number of incident cases of Gastric Cancer
* In the EU4 and the UK nations, Italy has the highest incidence rate at 24.7 per 100,000, trailed by Spain (23.1), Germany (21.6), France (17.0), and the UK (14.2).
* Key Gastric Cancer Companies: Hubro Therapeutics, Cello Therapeutics, Idience, Leap Therapeutics, Eli Lilly and Company, BeiGene, Hutchison MediPharma, Astellas Pharma, Henlix Biotech, Jiangsu Hengrui Medicine, Neovii Biotech, Genmab/Janssen Biotech, Rapa Therapeutics LLC, HiberCell, Inc., and others
* Key Gastric Cancer Therapies: FMPV-1, CE008, Venadaparib, DKN-01, Abemaciclib, Tislelizumab, Fruquintinib, Zolbetuximab, HLX10, Camrelizumab, Catumaxomab, Amivantamab, RAPA-201, HC 5404 FU, and others
* The Gastric Cancer epidemiology based on gender analyzed that gastric cancer is 2.2 times more likely to be diagnosed in males than females
* The Gastric Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gastric Cancer pipeline products will significantly revolutionize the Gastric Cancer market dynamics.
Gastric Cancer Overview
Gastric cancer, also known as stomach cancer, refers to the development of malignant tumors in the lining of the stomach. It typically begins in the innermost layer of the stomach wall and can gradually spread to other layers and nearby organs if not diagnosed and treated early. Gastric cancer is often asymptomatic in its early stages, making it challenging to detect, but as it progresses, symptoms may include indigestion, abdominal discomfort or pain, nausea, vomiting, unintentional weight loss, and blood in the stool.
Get a Free sample for the Gastric Cancer Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/gastric-cancer-market [https://www.delveinsight.com/report-store/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gastric Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Gastric Cancer Epidemiology Segmentation:
The Gastric Cancer market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Gastric Cancer
* Prevalent Cases of Gastric Cancer by severity
* Gender-specific Prevalence of Gastric Cancer
* Diagnosed Cases of Episodic and Chronic Gastric Cancer
Download the report to understand which factors are driving Gastric Cancer epidemiology trends @ Gastric Cancer Epidemiology Forecast [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gastric Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastric Cancer market or expected to get launched during the study period. The analysis covers Gastric Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Gastric Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Gastric Cancer Therapies and Key Companies
* FMPV-1: Hubro Therapeutics
* CE008: Cello Therapeutics
* Venadaparib: Idience
* DKN-01: Leap Therapeutics
* Abemaciclib: Eli Lilly and Company
* Tislelizumab : BeiGene
* Fruquintinib: Hutchison MediPharma
* Zolbetuximab: Astellas Pharma
* HLX10: Henlix Biotech
* Camrelizumab: Jiangsu Hengrui Medicine
* Catumaxomab: Neovii Biotech
* Amivantamab: Genmab/Janssen Biotech
* RAPA-201: Rapa Therapeutics LLC
* HC 5404 FU: HiberCell, Inc.
Discover more about therapies set to grab major Gastric Cancer market share @ Gastric Cancer Treatment Landscape [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Gastric Cancer Market Strengths
* In-depth understanding of molecular heterogeneity of tumor and pathogenesis
* Scientific advances and identification of novel therapeutic targets for treatment
Gastric Cancer Market Opportunities
* Future development of potential biomarkers may improve screening and early detection of gastric cancers, with better accuracy, in the future.
* Increase in the awareness of gastric cancers and encouraging regular screening.
Scope of the Gastric Cancer Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Gastric Cancer Companies: Hubro Therapeutics, Cello Therapeutics, Idience, Leap Therapeutics, Eli Lilly and Company, BeiGene, Hutchison MediPharma, Astellas Pharma, Henlix Biotech, Jiangsu Hengrui Medicine, Neovii Biotech, Genmab/Janssen Biotech, Rapa Therapeutics LLC, HiberCell, Inc., and others
* Key Gastric Cancer Therapies: FMPV-1, CE008, Venadaparib, DKN-01, Abemaciclib, Tislelizumab, Fruquintinib, Zolbetuximab, HLX10, Camrelizumab, Catumaxomab, Amivantamab, RAPA-201, HC 5404 FU, and others
* Gastric Cancer Therapeutic Assessment: Gastric Cancer current marketed and Gastric Cancer emerging therapies
* Gastric Cancer Market Dynamics: Gastric Cancer market drivers and Gastric Cancer market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Gastric Cancer Unmet Needs, KOL's views, Analyst's views, Gastric Cancer Market Access and Reimbursement
To know more about Gastric Cancer companies working in the treatment market, visit @ Gastric Cancer Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Gastric Cancer Market Report Introduction
2. Executive Summary for Gastric Cancer
3. SWOT analysis of Gastric Cancer
4. Gastric Cancer Patient Share (%) Overview at a Glance
5. Gastric Cancer Market Overview at a Glance
6. Gastric Cancer Disease Background and Overview
7. Gastric Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Gastric Cancer
9. Gastric Cancer Current Treatment and Medical Practices
10. Gastric Cancer Unmet Needs
11. Gastric Cancer Emerging Therapies
12. Gastric Cancer Market Outlook
13. Country-Wise Gastric Cancer Market Analysis (2019-2032)
14. Gastric Cancer Market Access and Reimbursement of Therapies
15. Gastric Cancer Market Drivers
16. Gastric Cancer Market Barriers
17. Gastric Cancer Appendix
18. Gastric Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gastric-cancer-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20232032-states-delveinsight-beigene-hutchison-medipharma-astellas-pharma-hubro-therapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | BeiGene, Hutchison MediPharma, Astellas Pharma, Hubro Therapeutics here
News-ID: 3467671 • Views: …
More Releases from ABNewswire
Virguez Law Offers Trusted Legal Assistance for Car Accident Victims in Georgia …
Virguez Law, a respected firm known for its work in personal injury and immigration law, continues to provide reliable and accessible legal representation for car accident victims in Georgia and Charlotte, North Carolina. The firm helps injured individuals seek justice and compensation following vehicle collisions caused by negligence.
Georgia & North Carolina - October 2, 2025 - Virguez Law, a respected firm known for its work in personal injury and immigration…
Minga Orthodontics Expands Access to Expert-Led Orthodontic Treatments with a Fo …
Minga Orthodontics delivers expert orthodontic treatments with a focus on precision, comfort, and patient education. As a top provider for those searching orthodontic treatments near me, the clinic is trusted for high-quality orthodontic treatments Delaware and orthodontic treatments Delaware OH. With advanced technology, personalized plans, and community-driven care, Minga Orthodontics is setting a new standard in modern orthodontics for all ages.
In today's evolving dental care landscape, patients expect more from…
FrankNez Media: Artificial Intelligence is Now Reshaping America's Schools in Un …
Image: https://www.abnewswire.com/upload/2025/10/408f1bece0a91f9fc3436b462f38f68f.jpg
DES MOINES - It feels like the beginning of a new era, not just another school year, as students return to classes across the United States. Artificial intelligence (AI) is transforming how schools work in far-reaching and profound ways. What once seemed futuristic is occurring now, and it will bring deep changes to teachers, students, and school leaders.
The emergence of AI-driven platforms seemingly overnight has technology enthusiasts cheering, skeptics…
Honoring Her: The First Mother's Day Without Mom Gift - Giftlips
Image: https://www.abnewswire.com/upload/2025/10/b846bcb75dad8a71c2b8a90b1eb0a0d1.jpg
New York City - Mother's Day, a time typically filled with joy and celebration, can evoke a profound sense of emptiness and longing for those experiencing their first Mother's Day without mom.
This poignant milestone brings a unique set of emotions, often amplifying the process of grief. Recognizing this delicate period, GiftLips offers guidance and a compassionate tool to help individuals navigate this challenging day by transforming sorrow into meaningful…
More Releases for Gastric
Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Cancer Drugs Market Size By 2025?
In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market?
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,…
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market?
The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that…
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gastric Cancer…
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market.
Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126
The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
